uz
Feedback
Intraday Trading Solution👍

Intraday Trading Solution👍

Kanalga Telegram’da o‘tish

This channel is truly for educational purposes. And If you earn profits from our levels . NSE REGISTERED AP . Contact Your Financial Advisor Before Taking Trades. #NIFTY #BANKNIFTY #CRUDEOIL #INTRADAY #STOCKS # SHARE MARKET

Ko'proq ko'rsatish
6 525
Obunachilar
-724 soatlar
-707 kunlar
-22230 kunlar
Postlar arxiv
113🔥

112🔥

110🔥

108🔥

105🔥

102🔥

100🔥

106 to 115🔥TG1 Done ✅ enjoy guys keep booking profit on target 🎯 Qty 375× 9= 3375rs./Lot done
106 to 115🔥TG1 Done ✅ enjoy guys keep booking profit on target 🎯 Qty 375× 9= 3375rs./Lot done

115🔥

114🔥

111🔥

109🔥

107🔥

106🔥

✅INTRADAY+SWING✅ BUY COFORGE JUNE 1700CE AROUND 85-105 TRG 110/117/125 wait for activation near Entry point

Technical view of Nifty 50 A sustainable move above the resistance of 24,900 could pull Nifty towards another hurdle at 25,200 in the near term; however, immediate support is placed at 24,600 levels.

Technical view of Banknifty A move above 55,900 will trigger short covering towards 56,100, while a breakout above 56,100 can extend the rally to 56,400. On the downside, immediate support is placed at 55,600.

STOCKS IN THE WATCH UPL: Serra Bonita, an associate company, plans to sell its entire assets for ₹125 million. UPL holds a 33 per cent stake in Serra Bonita and is set to benefit from this transaction, as the proceeds will be distributed among the shareholders.    Infosys:The Director General of GST Intelligence(DGGI) has closed the pre-show cause notice proceedings for the financial years 2018-19 to 2021-22, involving a GST amount of ₹32,403 crore, the company informed exchanges. "With the receipt of today’s communication from DGGI, this matter stands closed," it added.   Lupin: The pharmaceutical company has received tentative approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Oxcarbazepine Extended-Release (ER) Tablets in 150 mg, 300 mg, and 600 mg strengths. It is the generic equivalent of Supernus Pharmaceuticals’ Oxtellar XR. The drug is used to treat partial-onset seizures in patients aged six and above. The product will be manufactured at Lupin’s Nagpur facility in India.   Mahindra & Mahindra: The automobile major reported total production of 89,626 units in May 2025, up 27.6 per cent from 70,261 units in the year-ago period. The company's total sales increased 16.6 per cent year-ono-year (Y-o-Y) to 80,458 units in May 2025 compared to 60,011 units in the May 2024.    Bharat Electronics: The company has signed a memorandum of understanding (MoU) with Tata Electronics to collaborate on semiconductor and electronics solutions.   GHV Infra Projects: The infrastructure company has received an order worth ₹546 crore (excluding GST) from GHV (India) for the strengthening and improvement of various roads in Mumbai. The project is scheduled to be completed within 24 months.    Nazara Technologies: The company has acquired Smaaash Entertainment for ₹126 crore, turning it into a wholly owned subsidiary.    JK Cement: The company has completed the acquisition of a 60 per cent stake in Saifco Cements for ₹149.8 crore.